IFR128
BioSciences Gerland - Lyon Sud |
U851
INSERM-UCBL "Immunité, Infection, Vaccination" |
Immunité
des muqueuses, vaccination et tolérance. |
Responsable
d'équipe : |
|||
Adresse
: |
INSERM
U851 21 avenue Tony Garnier 69365 Lyon Cedex 07 |
||
Téléphone
: |
+ 33 (0)4 37 28 23 94 | ||
Fax
: |
+ 33 (0)4 37 28 23 91 | ||
E-mail
: |
dominique.kaiserlian@inserm.fr |
Research projects : | |
The research projects of the team are focused on the mechanisms of induction and regulation of immune responses, generated by penetration and/or delivery of model antigens, (allergens and vaccines) via mucosal tissues and skin. The team is specialized in the development of animal models of patho-physiological relevance to allergic and inflammatory diseases and models suitable for the in vivo testing anti-infectious vaccines. The team is also devoted to development of clinical studies in human. These include pathophysiological studies of chronic allergic and inflammatory diseases affecting the intestine (food allergy, Crohn disease, IPEX) and the skin (contact dermatitis) and therapeutic clinical studies on the safety and efficacy of novel routes of vaccination against infectious diseases. In recent years the
main advances include the following areas: |
|
(i) Dynamics and function of dendritic cells in skin and mucosal epithelia. We have shown that dendritic cells (DC) recruited in pluristratified mucosal epithelia and derived from circulating monocytes, are responsible for presentation of vaccine antigens and allow for in vivo cross priming of CD8 CTL in vivo. The CCR6/CC20 pathway plays a key role in the efficacy of adjuvants to induce such CD8 CTL responses. (ii) Mechanisms of oral tolerance to environmental and food antigens. We have shown that regulatory CD4+ T cells are required for oral tolerance and prevent systemic DTH responses mediated by CD4 and CD8+ T cells. We have identified the immunosuppressive potential of plasmacytoid DC and the crucial role of liver pDC in the induction of oral tolerance. (iii) Role of CD8+ T cells in chronic inflammatory bowel diseases. We have We developed news models of colitis in mice showing that gut inflammation results from a DTH response to self and environmental antigens, mediated by CD8+ T cells. IFNg-producing cytotoxic CD8 CTL initiate relapsing colitis and upon migration to the colon can induce cytolysis of epithelial cells. This indicates that in IBD, CD8 may come before CD4 to initiate the inflammatory cascade. (iv) Mucosal vaccination for CD8+ CTL priming. Danger signals provided by adjuvants or pathogens administered via mucosal or skin sites allow for initiation of systemic as well as mucosal immunity. A clinical study in healthy human volunteers shows that topical vaccination against measles using a patch is able to induce measles-specific mucosal IgA . |
Main publications : |
|
|
|
|
|
|
|
|
|
|